Berberine associated to SGLT2i Dapagliflozin synergistically reduces cardiac cell apoptosis during exposure to Trastuzumab through reduction of AGEs and IL-6 and induction of pAMPK
27 August 2022 (12:15 - 13:00)
Organised by:
Abstract
Slides
About the speaker
National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
6 More presentations in this session
Associate Professor M. Schmidt (Aarhus, DK)
Mrs N. Nouhravesh (Durham, US)
Mr E. Fort (Barcelona, ES)
Access the full session
The Event
ESC Congress 2022
27 August 2022
12:15 CET
